Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Total Current Liabilities
All obligations due within one year.
Shoulder Innovations, Inc.NYSE: SI
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 76.6% from a year ago
Total current liabilities stood at $12.34M at the end of Q1 FY2026, up 76.6% from a year earlier and up 258.8% from the prior quarter.
Context
- Total current liabilities amounted to 7.7% of total assets at the end of Q1 FY2026, down 4.5 pp from a year earlier.
- Total current liabilities increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +76.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- (7.77M) USD
- Year-over-year change
- -201.6%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (7.77M) | -201.6% |
| FY2024 | 2024-12-31 | 7.65M | +78.5% |
| FY2023 | 2023-12-31 | 4.28M | — |
Total Current Liabilities vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 total current liabilities of $12.34M is the 8th highest of the 11 companies compared; the peer median is $26.65M.
- Its year-over-year change of +76.6% is the 3rd highest of 11, against a peer median of +1.7%.
- Total current liabilities amounts to 7.7% of total assets for SI, versus a peer median of 14.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $61.45M | -6.1% | -0.9% | 21.5% | |
| Mar 2026 | $46.44M | +1.1% | +17.6% | 14.8% | |
| Mar 2026 | $37.61M | +9.9% | -10.2% | 15.1% | |
| Jun 2026 | $37.4M | -9.2% | +39.4% | 28.3% | |
| Mar 2026 | $35M | -24.9% | +44.1% | 14.9% | |
| Mar 2026 | $18.3M | -61.3% | -33.3% | 49.3% | |
| Dec 2025 | $16.89M | +20.9% | -12.3% | 10.4% | |
| Mar 2026 | $12.34M | +76.6% | — | 7.7% | |
| Mar 2026 | $11.6M | +94.2% | +160.7% | 11.8% | |
| Mar 2026 | $8.34M | +2.3% | +5.4% | 4.7% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $7.39M | +235.8% | +10.8% | 5.1% |
| Peer median (excluding SI) | $26.65M | +1.7% | +8.1% | 14.8% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.